WHO expands contraceptive guidelines, backs longer-acting methods and male contraceptives

The WHO issued updated guidelines broadening contraceptive options, including extended use of existing methods, mifepristone for emergency contraception, and support for developing male contraceptives. This is a policy shift in global reproductive health guidance, potentially affecting national health programs and pharmaceutical R&D priorities. The impact is gradual and policy-oriented rather than immediate market-moving.